alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 10.28

                                   TRANSMEDIA
                                        NETWORK INC

January 29, 1997

Mr. Stephen E. Lerch
4106 Brambletye Drive
Greensboro, NC 27407

Dear Steve:

The following expresses my understanding of the terms we discussed during our
telephone conversation.

 1. I will recommend to the Board that you be elected as Executive Vice
    President.

 2. I will recommend that the Stock Option Committee award you ten thousand
    (10,000) shares under our Qualified Stock Option Plan.

 3. You will receive a base salary of two hundred thousand dollars ($200,000)
    per annum for the first fiscal year (ending September 30, 1997) and a
    minimum bonus of fifteen thousand dollars ($15,000) for that year.

 4. You will receive one thousand dollars ($1,000) per month car allowance.

 5. The company will pay you a signing bonus of sixth thousand dollars
    ($60,000), less applicable taxes.

 6. The company will loan you fifty-five thousand dollars ($55,000) at six
    percent (6%) interest, to be accrued (it is anticipated that future bonuses,
    other than the $15,000, will be used, in whole or in part, to amortize 
    this loan). 

 7. Your salary will commence as of Saturday, February 1, 1997.

 8. You will receive a Transmedia Card, for business and personal use, at no
    cost to you.

 9. During the transition period, you will be responsible for your personal
    expenses, but the company will pay expenses for both you and your family
    when visiting Florida until such time as you move here. It is anticipated
    that you will move as quickly as possible and that you will make every
    effort to sell your house by June 30, 1997.

10. The company will pay all reasonable moving expenses.

<PAGE>

Stephen E. Lerch
Page 2
January 29, 1997


11. You and your family will be covered under the company's medical insurance
    effective February 1, 1997.

12. In the event of a change of control of the company, for one year after that
    change of control, should you not be offered a comparable position,
    comparable salary, or be asked to relocate, you shall have the option of
    receiving a single lump sum payment of five hundred thousand ($500,000).

If you are in agreement with the above, please sign in the space indicated
below.

Very truly yours,

/s/ MELVIN CHASEN
-----------------------------
Melvin Chasen
President

ACCEPTED BY:


/s/ STEPHEN E. LERCH                      Date: 1:29-97
--------------------------                     ----------------------
Stephen E. Lerch
# Official Journal C 235/2020

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 235 |
| | |
| English edition | Information and Notices | Volume 6317 July 2020 |

ISSN 1977-091X

Official Journal

of the European Union

C 235

English edition

Information and Notices

Volume 6317 July 2020

---

| Contents | page |
| --- | --- |
| | IV   Notices |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2020/C 235/01 | Euro exchange rates — 16 July 2020 | 1 |
| | NOTICES FROM MEMBER STATES |
| 2020/C 235/02 | Information communicated by Member States regarding closure of fisheries | 2 |
| 2020/C 235/03 | Information communicated by Member States regarding closure of fisheries | 3 |

Contents

page

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2020/C 235/01

Euro exchange rates — 16 July 2020

1

NOTICES FROM MEMBER STATES

2020/C 235/02

Information communicated by Member States regarding closure of fisheries

2

2020/C 235/03

Information communicated by Member States regarding closure of fisheries

3

---

| | V   Announcements |
| --- | --- |
| | PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY |
| | European Commission |
| 2020/C 235/04 | Prior notification of a concentration (Case M.9812 – Verily Life Sciences/Santen Pharmaceutical/JV) Candidate case for simplified procedure (
  1
  ) | 4 |
| 2020/C 235/05 | Prior notification of a concentration (Case M.9711 – Alliance Healthcare Deutschland/Gehe Pharma Handel) (
  1
  ) | 6 |
| | OTHER ACTS |
| | European Commission |
| 2020/C 235/06 | Publication of an application for registration of a name pursuant to Article 50(2)(a) of Regulation (EU) No 1151/2012 of the European Parliament and of the Council on quality schemes for agricultural products and foodstuffs | 7 |

V   Announcements

PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY

European Commission

2020/C 235/04

Prior notification of a concentration (Case M.9812 – Verily Life Sciences/Santen Pharmaceutical/JV) Candidate case for simplified procedure (
  1
  )

1

4

2020/C 235/05

Prior notification of a concentration (Case M.9711 – Alliance Healthcare Deutschland/Gehe Pharma Handel) (
  1
  )

1

6

OTHER ACTS

European Commission

2020/C 235/06

Publication of an application for registration of a name pursuant to Article 50(2)(a) of Regulation (EU) No 1151/2012 of the European Parliament and of the Council on quality schemes for agricultural products and foodstuffs

7

---

| | |
| --- | --- |
| | (1)   Text with EEA relevance. |

---

(1)   Text with EEA relevance.

1

| EN | |
| --- | --- |

EN
**Exhibit 12.1****COLONIAL REALTY LIMITED PARTNERSHIP****Ratio of Earnings to Fixed Charges**           **For the three-month period**  **ended March 31,***(all dollar amounts in thousands)* **2008** **2007**    **Earnings:**        Pre-tax income (loss) before adjustment for minority interest inconsolidated subsidiaries or income, loss from equity investees,extraordinary gain or loss, or gains on sale of properties $1,698  $(3,692)Amortization of interest capitalized  900   600 Interest capitalized  (6,336)  (6,245)Distributed income of equity investees  3,217   2,335 Fixed charges  25,003   35,806             Total Earnings $24,482  $28,804             **Fixed Charges:**        Interest expense $17,479  $27,904 Capitalized interest  6,336   6,245 Debt costs amortization  1,188   1,657             Total Fixed Charges $25,003  $35,806             **Ratio of Earnings to Fixed Charges**  (a)  (a)    a) *For the three months ended March 31, 2008 and 2007,the aggregate amount of fixed charges exceeded ourearnings by approximately $0.5 million and $7.0million, respectively, which is the amount ofadditional earnings that would have been required toachieve a ratio of earnings to fixed charges of 1.0xfor such period. The deficiency of the ratio ofearnings to fixed charges for all periods presentedis primarily due to the classification of operationsfor assets held for sale and sold as discontinuedoperations.*The ratios of earnings to fixed charges were computed by dividing earnings byfixed charges. For this purpose, earnings consist of pre-tax income fromcontinuing operations before adjustment for minority interest in consolidatedsubsidiaries or income or loss from equity investees, gains on sale ofproperties, distributed income of equity investees, fixed charges andamortization of capitalized interest excluding interest costs capitalized.Fixed charges consist of interest expense (including interest costscapitalized) and amortization of debt issuance costs.
41
# C_2022484EN.01001401.xml

| 20.12.2022 | EN | Official Journal of the European Union | C 484/14 |
| --- | --- | --- | --- |

20.12.2022

EN

Official Journal of the European Union

C 484/14

---

Non-opposition to a notified concentration

(Case M.10913 – SADCO / HACP / JV)

(Text with EEA relevance)

(2022/C 484/03)

On 9 December 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10913. EUR-Lex is the online point of access to European Union law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10913. EUR-Lex is the online point of access to European Union law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
#### MORTON v. STATE.

No. 15380.

Court of Criminal Appeals of Texas.

Nov. 16, 1932.

Fred Erisman, of Longview,, for appellant.

Lloyd W. Davidson, State’s Atty., of Austin, for the State.

HAWKINS, J.

Conviction is for burglary; punishment assessed at five years in the penitentiary.

The record contains neither statement of facts nor bills of exception. In such condition nothing is presented for review.

The judgment is affirmed.
**EXHIBIT32.2**

 

**THE PENN TRAFFIC COMPANY**

 

CERTIFICATION PURSUANT TO18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Inconnection with the Annual Report of The Penn Traffic Company (the “Company”)on Form 10-K/A for the fiscal year ending January 28, 2006, as filedwith the Securities and Exchange Commission on the date hereof (the “Report”),I, Tod A. Nestor, Senior Vice President and Chief Financial Officer of theCompany, certify, pursuant to 18 U.S.C. Section 1350, as adoptedpursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

# (1)              The Report fully complies with therequirements of Section 13(a) or 15(d) of the SecuritiesExchange Act of 1934; and

#  

# (2)              The information contained in the Reportfairly presents, in all material respects, the financial condition and resultsof operations of the Company.

#  

 
| /s/  Tod A. Nestor                                 |   |
|----------------------------------------------------|--------|
| Tod  A. Nestor                                     |
| Senior  Vice President and Chief Financial Officer |

 

May 8,2008

 

----
NOTE: This disposition is nonprecedential. 

 United States Court of Appeals for the Federal Circuit 

2007-5053 

DIE CASTERS INTERNATIONAL, INC., 

 

Plaintiff-Appellant, 

v. 

UNITED STATES, 

Defendant-Appellee. 

 Gary Marcus, Gary Marcus Attorney At Law, P.C., of Garden City, New York, 

argued for plaintiff-appellant. 

Leslie Cayer Ohta, Attorney, Commercial Litigation Branch, Civil Division, United 

States Department of Justice, of Washington, DC, argued for defendant-appellee. With 

her on the brief were Peter D. Keisler, Acting Attorney General, Jeanne E. Davidson, 

Director, and Bryant G. Snee, Deputy Director. 

Appealed from: United States Court of Federal Claims 

Judge Susan G. Braden 
NOTE: This disposition is nonprecedential. 

United States Court of Appeals for the Federal Circuit

2007-5053 

DIE CASTERS INTERNATIONAL, INC., 

 Plaintiff-Appellant, 

v. 

UNITED STATES, 

 Defendant-Appellee. 

 

Judgment 

ON APPEAL from the UNITED STATES COURT OF FEDERAL CLAIMS 

 

in CASE NO(S). 04-CV-1113

This CAUSE having been heard and considered, it is 

ORDERED and ADJUDGED: 

 Per Curiam (SCHALL, Circuit Judge, CLEVENGER, Senior Circuit Judge, and 

 MOORE, Circuit Judge.) 

 AFFIRMED. See Fed. Cir. R. 36. 

 ENTERED BY ORDER OF THE COURT

DATED: October 9, 2007 /s/ Jan Horbaly 

 Jan Horbaly, Clerk
[Federal Register Volume 89, Number 187 (Thursday, September 26, 2024)]
[Notices]
[Page 78901]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-22068]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Medical CBRN Defense Consortium

    Notice is hereby given that, on July 2, 2024, pursuant to section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), Medical CBRN Defense Consortium 
(``MCDC'') has filed written notifications simultaneously with the 
Attorney General and the Federal Trade Commission disclosing changes in 
its membership. The notifications were filed for the purpose of 
extending the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances. 
Specifically, Alamgir Research Inc DBA ARIScience, Wayland, MA; 
American Additive Manufacturing LLC, Horsham, PA; Amyris Inc, 
Emeryville, CA; Arnasi 701 LLC, Woburn, MA; Columbus Nanoworks, 
Columbus, OH; Genetic Networks LLC, Miami Beach, FL; Radiation 
Monitoring Devices Inc, Watertown, MA; and Repurposed Therapeutics Inc, 
Saint Louis, MO, have been added as parties to this venture.
    Also, Clarifia Inc, New York, NY; Conductive Technologies Inc, 
York, PA; Government Scientific Source, Reston, VA; Kleo 
Pharmaceuticals, New Haven, CT; Locus Biosciences, Morrisville, NC; 
Pertexa Healthcare Technologies, Ridgecrest, CA; SX2 Technologies LLC, 
Port Washington, WI; and Trauma Insight LLC dba LumaBridge LLC, San 
Antonio, TX, have withdrawn as parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and MCDC intends to file additional 
written notifications disclosing all changes in membership.
    On November 13, 2015, MCDC filed its original notification pursuant 
to section 6(a) of the Act. The Department of Justice published a 
notice in the Federal Register pursuant to section 6(b) of the Act on 
January 6, 2016 (81 FR 513).
    The last notification was filed with the Department on April 2, 
2024. A notice was published in the Federal Register pursuant to 
section 6(b) of the Act on June 21, 2024 (89 FR 52096).

Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2024-22068 Filed 9-25-24; 8:45 am]
BILLING CODE P
# C_2023154EN.01000101.xml

| 2.5.2023 | EN | Official Journal of the European Union | C 154/1 |
| --- | --- | --- | --- |

2.5.2023

EN

Official Journal of the European Union

C 154/1

---

Non-opposition to a notified concentration

(Case M.10687 – D’IETEREN / PHE)

(Text with EEA relevance)

(2023/C 154/01)

On 2 August 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) in conjunction with Article 6(2) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10687. EUR-Lex is the online point of access to European Union law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10687. EUR-Lex is the online point of access to European Union law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
Exhibit 32.2








Chief Financial Officer’s Certification required under Section 906 of Sarbanes-Oxley Act of 2002





In connection with the quarterly report of TIB Financial Corp. (the “Company”) on Form 10-Q for the period ended March 31, 2011, as filed with the Securities and Exchange Commission (the “Report”), I, Christopher G. Marshall, Chief Financial Officer of the Company, certify pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that this Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that, to my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.








Date:           May 16, 2011
/s/ Christopher G. MarshallChristopher G. Marshall

Chief Financial Officer











A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to TIB Financial Corp. and will be retained by TIB Financial Corp. and furnished to the Securities and Exchange Commission or its staff upon request.
Exhibit 23

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We
hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-42899, No. 33-32367,
No. 30-40559, No. 333-41950, 333-00276, No. 333-10227) of Precision Castparts Corp. of our report dated June 16, 2005
relating to the financial statements, financial statement schedule, management's assessment of the effectiveness of internal control over financial reporting and the effectiveness of internal control
over financial reporting, which appears in this Form 10-K.

|/s/PRICEWATERHOUSECOOPERS LLPPricewaterhouseCoopers LLP |  | 
|------------------------------------------------------- |  | 

Portland, Oregon
June 16, 2005

---



QuickLinks
Final Listing of Questionnaire Files for Steam Electric Rulemaking Record

Plant ID 00664

Removed 

from Public 

(Non-CBI) 

Docket1

Copyright 

Flag2

File Name Description

x 00664\00664_Checklist.xls EPA Technical Review Checklist Workbook

00664\00664_Completeness_Checklist.xls EPA Completeness Review Checklist

00664\00664_HardcopyLog.doc EPA log of hardcopy documents submitted

x 00664\00664_Part A.xls Plant submitted survey file

x 00664\00664_Part B.xls Plant submitted survey file

x 00664\00664_Part C.xls Plant submitted survey file

x 00664\00664_Part D.xls Plant submitted survey file

x 00664\00664_Part H.xls Plant submitted survey file

00664\Certification Statment Plant ID 00664.pdf Plant certification statement

x 00664\Copy of 00664_Checklist.xls EPA Technical Review Checklist Workbook

x 00664\Supplemental Documents\(1 31 2011) Nerija Orentas - flyash system and ponds 00664 Follow up_BV.pdf Questions for Follow Up

x 00664\Supplemental Documents\(1 31 2011) Nerija Orentas - Re Steam electric survey response questions.pdf Email communications regarding questions on the survey response

00664\Supplemental Documents\00664_A5-2-BV- Map 1.pdf Plant submitted supplemental files to the survey

00664\Supplemental Documents\00664_A5-2-BV- Map 2.pdf Plant submitted supplemental files to the survey

x 00664\Supplemental Documents\00664_BV water mass balance 10-1.pdf Plant submitted supplemental files to the survey

1

 Final reviewed survey responses are located in the Steam Electric Technical Questionnaire Database . 

2

 Copyright documents are available from the docket.
#### Zeltner, Appellant, *v.*Zeltner et al., Appellees.

(No. 28935

Decided January 14, 1942.)

*Mr. Grover G. Hoff, Mr. Marcus Downing*and *Mr. Wm. Dunipace,*for appellant.

*Mr. G. Cecil Huntsman*and *Mr. James Donovan, Jr.,*for appellees.

It is ordered and adjudged that this appeal as of right be, and the same hereby is, dismissed for the reason that no debatable constitutional question is involved.

*Appeal dismissed.*

Weygandt, C. J., Turner, Williams, Matthias, Hart, Zimmerman and Bettman, JJ., concur.
1

Ogulei, David

From: Wilson, Darnell

Sent: Wednesday, May 06, 2015 9:23 AM

To: Ogulei, David

Cc: Lambesis, Christopher; Ramaly, Todd

Subject: RE: Veolia Draft Title V Permit

Good morning David, 

I researched your issue below and spoken with HQs as well as the state of OH and IL. Based on what we have in our 

state and federal system the following data represents Veolia, Ross and Heritage: 

Veolia received 1823 LQG records of waste received in the amount of 22,285 tons for 2013. The also received 8,628 tons 

of waste received from SQG/CESQG. We have no way of knowing the number of SQGs and CESQGs because they’re not 

counting as a generator on the Biennial Report just their waste. The total waste received 30,912.52 tons. 

Heritage received 3128 LQG records of waste received in the amount of 31,548 tons. They also received 14,050.75 tons 

of waste received from SQG/CESQG. The total waste received for Heritage was 45,598 tons. 

Ross received 2759 LQG records of waste in the amount of 38,522.66 tons. They also received 35,657.36 tons of waste 

received from SQG/CESQG. The total waste received from Ross was 74,180.02 tons for 2013 the latest data available. 

We’re unable to decipher how Veolia was able to get the data they have in the table. The data from EI Digest is a 

publication and not current data. According to HQs the publication contacts people on the biennial report and get 

annual calculations. These are quotes and not actual numbers. We also don’t know if EI Digest is doing a random 

sample or calling each generator in the country. That’s something you would need to find out from EI Digest. 

According to the state of OH in 2011 the WR (Waste Received) from Ross was 65,046 tons and Heritage was 42,962 

tons. Also from the 2011 RCRA C incinerated from the state of OH; Ross incinerated 63,425 tons and Heritage 42,962 

tons. 

In 2013 Veolia Had 80 records from the form G31-G49 which is spills and accidental as well as remediation of past 

contamination which would be considered one-time. Ross had 150 records from form G31-G49 and Heritage had 157 

records from the G31-G49 forms. 

I was unable to tell how Veolia used the algorithm to get those numbers. Based on our data we have on file as well as 

state and verified through HQs the data is available above. I am setting up a meeting invite to discuss the data this 

afternoon. In the meantime if you have any questions please let me know. 

Regards, 

Darnell L. Wilson 

U.S. EPA Region 5 (LP-9J) 

RCRAInfo/BR Coordinator 

Ph: (312)886-4759 

Fax: (312)697-2590 

Email: wilson.darnell@epa.gov

 Please consider the environment before printing this message.
```

CONFIRMING STATEMENT

    This statement confirms that the undersigned, John J. Martin, has authorized and designated, Jennifer Mainord, Deanna Brass or Rhonda Bost, to execute and file on the undersigned's behalf, all Form 3, 4, and 5 (including amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned's ownership of or transactions in securities of First Merchants Corporation.  The authority of Jennifer Mainord, Deanna Brass or Rhonda Bost under this statement shall continue until the undersigned is no longer required to file Form 3, 4, and 5 with regard to the undersigned ownership or transactions in securities of First Merchants Corporation, unless earlier revoked in writing.  The undersigned acknowledges Jennifer Mainord, Deanna Brass or Rhonda Bost are not assuming any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

                        __/s/ John J. Martin______
                        John J. Martin

Date: December 8, 2014
```